DUBLIN--(BUSINESS WIRE)--The "Parenteral Nutrition Bags Market by Chamber Type (Single-Chamber Bags, Dual-Chamber Bags, Multi-Chambered Bags), Consumer (Adults, Children), End User...
Industry Recognition: Stemtech Ranked Top 5% in Direct Selling by 'Business for Home'"NAPLES, FL / ACCESSWIRE / April 19, 2024...
NAPOLEONVILLE, LA / ACCESSWIRE / April 18, 2024 / Impact Fusion International Inc. ("The Company") (OTC PINK:IFUS) is pleased to...
IND to be filed with the FDA in the coming weeksPARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 18,...
TORONTO, ON / ACCESSWIRE / April 17, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
Jaguar planning to begin commercial launch in Q3 2024 for Gelclair®, the company's third prescription productOral mucositis, also called "chemo...
80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded...
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius SE, with an intravenous and subcutaneous...
TORONTO, ON / ACCESSWIRE / April 15, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update on its...
Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 30% Year-Over-Year EPS Grew 45% Year-Over-Year TAMPA, Fla.,...
Collaboration Includes Robust Education and Training to Support Radiologists and Imaging SpecialistsWHIPPANY, N.J.--(BUSINESS WIRE)--Bayer and Hologic, Inc. (Nasdaq: HOLX) today...
PLANO, TX / ACCESSWIRE / April 9, 2024 / In a partnership that signals a game-changing moment for athletic nutrition,...
Toronto, Ontario--(Newsfile Corp. - April 8, 2024) - Celly Nutrition Corp. ("Celly Nu" or the "Company"), announced today that it...
Profitable Acquisition Expected to Contribute More than $8 Million of Annualized Revenue and Over $1 Million of Adjusted EBITDAMIAMI, April...
Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or...
Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2026NEW YORK, April 05,...
New development pathway significantly expands addressable patient population for IV Choline ChlorideIV Choline Chloride has the potential to become the...
2024 Myeloma Action Month Global Campaign Brings Wave of Myeloma Awareness to 36 Countries WorldwideSTUDIO CITY, Calif., April 04, 2024...
SAN FRANCISCO, CA / ACCESSWIRE / April 3, 2024 / Allara Health released the first study to investigate the impact...
ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer of...